cyclosporine and Familial Combined Hyperlipidemia

cyclosporine has been researched along with Familial Combined Hyperlipidemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aguilar-Salinas, CA; Alberú, J; Arellano, A; Correa-Rotter, R; Díaz-Polanco, A; Gómez Pérez, FJ; Macias, N; Ordóñez, ML; Quintana, E; Ramírez, E; Velásquez-Alva, C1

Other Studies

1 other study(ies) available for cyclosporine and Familial Combined Hyperlipidemia

ArticleYear
Genetic factors play an important role in the pathogenesis of hyperlipidemia post-transplantation.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:1

    Topics: Adult; Apolipoproteins E; Body Composition; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraindications; Cyclosporine; Diet; Female; Genetic Predisposition to Disease; Graft Survival; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Male; Mexico; Sex Factors; Surveys and Questionnaires

2002